Enabling T cell immunotherapy discovery, development and manufacturing
Intracellular delivery into T cells is a major bottleneck in T cell immunotherapy discovery, development, and manufacturing.
Indee Labs provides a non-viral intracellular delivery system using microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins, and gene-editing complexes into T cells with minimal perturbation.
Cell therapy biotechs, pharma companies, and research/manufacturing teams working with patient or donor T cells.
My career aim is to use technology to improve health outcomes. See more on my LinkedIn profile.





